Detalhe da pesquisa
1.
Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry.
Acta Derm Venereol
; 103: adv14153, 2023 Oct 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37800349
2.
A Multicentre Randomised Controlled Study Evaluating the Effect of a Standardised Education Programme on Quality of Life, Disease Severity, and Disease Knowledge in Patients with Moderate-To-Severe Psoriasis: The EDUPSO Study.
Dermatology
; 238(4): 630-639, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-34883480
3.
Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis.
Acta Derm Venereol
; 100(18): adv00316, 2020 11 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33111960
4.
Socioeconomic Inequalities and Severity of Plaque Psoriasis at a First Consultation in Dermatology Centers.
Acta Derm Venereol
; 97(5): 632-638, 2017 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28127620
5.
[A psychotherapy can only allow to better live its psoriasis ]. / Une psychothérapie ne peut que permettre de mieux vivre son psoriasis .
Rev Prat
; 68(9): 981-983, 2018 Nov.
Artigo
Francês
| MEDLINE | ID: mdl-30869353
6.
Use of Methotrexate in the Treatment of Moderate to Severe Plaque Psoriasis in France: A Practice Survey.
Clin Cosmet Investig Dermatol
; 14: 389-393, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33935509
7.
Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis.
Drugs Aging
; 37(9): 657-663, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32696432
8.
Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis.
J Am Acad Dermatol
; 67(6): e280-2, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23158640